White Cell Disorders Flashcards

(28 cards)

1
Q

What are the clinical features of chronic granulomatous disease and what is the enzyme defect?

A

Recurrent skin and lung infections. The enzyme defect is NADPH oxidase deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the mode of inheritance of chronic granulomatous disease?

A

Mostly autosomal recessive, but some can be X-linked.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you treat chronic granulomatous disease?

A

You give these patients Bactrim and Itraconazole for prophylaxis. Can consider interferon gamma, BMT, and gene therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features of MPO deficiency?

A

Most patients are asymptomatic, however in those with uncontrolled diabetes the symptoms may be unmasked.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you make the diagnosis of MPO deficiency?

A

By histochemical staining for MPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the clinical features of Hyper IgE syndrome?

A

These patients develop skin, lung, sinus infections (often yeast)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What gene is affected in Hyper IgE syndrome?

A

STAT3 gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you diagnose chronic granulomatous disease?

A

Diagnosis is with nitroblue-tetrazolium reduction (cytochrome C reduction assay)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical features of Chediak Higashi Syndrome?

A

oculocutaneous albinism ,photophobia, mild neutropenia, neurologic defects (e.g. neuropathy), recurrent pyogenic infections, bleeding (dense platelet granule defect).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mode of inheritance of Chediak Higahsi and what is the gene mutation?

A

Autosomal recessive and the gene affected is LYST gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the treatment of Chediak Higahsi Syndrome?

A

BMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In cyclical neutropenia what is the mode of inheritance and what gene is involved?

A

Autosomal dominant and it’s the ELANE gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the major complication that can occur later in life with severe congenital neutropenia? What has been associated with this?

A

AML. It appears the longer patients are on G-CSF the higher risk is with this occurring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What somatic mutation occurs with G-CSF that increases the risk of AML in patients with severe congenital neutropenia?

A

CSF3R mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment of both congenital neutropenia and cyclical neutropenia?

A

G-CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the treatment of congenital neutropenia refractory to treatment?

17
Q

What are the clinical features of WHIM?

A

Warts, hypogammaglobulinemia, infections, and myelokathexis (increased marrow mature neutrophils).

18
Q

What genetic mutation characterizes WHIM? What is the result of this mutation?

A

There is a mutation involves the CXCR4 gene. Mutations result in enhanced retention of neutrophils in the bone marrow

19
Q

What is the treatment of WHIM syndrome?

A

IVIG, prophylactic antibiotics, and Plerixafor.

20
Q

What mutation is commonly seen in Langerhans Cell Histiocytosis?

A

Over 70% of cases have a somatic mutation in BRAF.

21
Q

What is the treatment of SS-LCH involving the bone?

A

Bony or soft tissue SS-LCH can be treated with surgical resection, local irradiation, or injection of steroids. NCCN lists Zoledronic Acid and Pamidronate-systemic tx for widespread disease.

22
Q

What is the treatment of skin SS-LCH?

A

topical steroids or injection, mechlorethamine topical, or psoralen and ultraviolet A light therapy, RT low dose. NCCN-MTX, hydrea (both preferred), Lenalidomide, Thalidomide-additional, but not preferred

23
Q

What is the treatment of lung SS-LCH?

A

Cessation of smoking, prednisone, vinblastine, and methotrexate; and immunosuppressive agents. NCCN: basically the systemic options you use for multi-system disease.

24
Q

What is the tx of MS-LCH and SS-LCH with multi-focal involvement?

A

Preferred: Cladribine or Cytarabine. MAP kinase mutation or no actionable mutation-Cobimetinib. Vinblastine and prednisone is another option.. Those with BRAF mutation you use Vemurafenib (preferred) or Dabrafenib.

25
What is flow cytometry result for Erdheim Chester Disease?
Positive for CD163 and CD68, CD14, but are negative for CD1a and langerin (CD207, unlike in LCH), and only rarely positive for S100.
26
What is the treatment of Erdheim Chester Disease?
NCCN: Vemurafenib (preferred) or dabrafenib for BRAF mutation. MAP kinase mutation or no detectable mutation: Cobimetinib (preferred) or Trametinib. Irrespective of mutation, other recs: Cladribine, Peg Interferon alpha, Sirolimis plus prednisone, MTX, Anakinra
27
What is the flow phenotype of LGL?
CD3+, CD16+, CD57+, CD28-
28
What is the flow phenotype for LCH?
CD1a, CD207 (Langerin), S100+, Cyclin D1+